Related Experiment Videos
Interindividual differences in response to plant-based diets: implications for cancer risk
1Fred Hutchinson Cancer Research Center and Nutritional Sciences Program, Department of Epidemiology, University of Washington, Seattle, WA, USA. jlampe@fhcrc.org
The American Journal of Clinical Nutrition
|March 20, 2009
Summary
Genetic variations impact how the body processes plant compounds, influencing cancer risk from plant-based diets. Understanding these genetic differences is key to personalized nutrition and cancer prevention strategies.
Area of Science:
- Nutritional Genomics
- Cancer Epidemiology
- Pharmacogenetics
Background:
- Dietary plant compounds (phytochemicals) interact with genetic factors to influence health outcomes, including cancer risk.
- Genetic polymorphisms in metabolic enzymes can alter the detoxification of carcinogens and the metabolism of protective phytochemicals.
- Individual responses to plant-based diets vary due to genetic predispositions affecting nutrient absorption and metabolism.
Purpose of the Study:
- To explore how genetic variations in metabolic enzymes affect the utilization of phytochemicals from plant-based diets.
- To investigate the role of genetic polymorphisms in biotransformation enzymes in modulating cancer risk associated with diet.
- To understand the interplay between host genetics, gut microbiota, and environmental factors in dietary cancer prevention.
Main Methods:
- Review of existing literature on genetic polymorphisms and their impact on phytochemical metabolism.
- Analysis of pharmacokinetic studies examining enzyme function and compound excretion.
- Discussion of specific gene polymorphisms, such as GSTM1 and those in UDP-glucuronosyltransferases and sulfotransferases.
Main Results:
- Genetic variations, like the GSTM1 null genotype, can lead to faster excretion of beneficial compounds like sulforaphane, potentially reducing cancer-protective effects from cruciferous vegetables.
- Polymorphisms in enzymes involved in flavonoid conjugation (e.g., UDP-glucuronosyltransferases, sulfotransferases) may influence phytochemical clearance and efficacy.
- Differential handling of carcinogens versus protective phytochemicals based on genotype can modify an individual's overall cancer risk.
Conclusions:
- Genetic polymorphisms in metabolic enzymes play a significant role in individual responses to plant-based diets and their impact on cancer risk.
- Personalized dietary recommendations considering genetic profiles may enhance the efficacy of plant-based diets for cancer prevention.
- Further research integrating host genetics, gut microbiome, and environmental exposures is crucial for a comprehensive understanding of diet-cancer relationships.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...